論文業績

Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study.

Jpn J Clin Oncol. 2024 Apr 6;54(4):403-415. doi: 10.1093/jjco/hyad189. PMID: 38251775

Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study.

Clin Colorectal Cancer. 2024 Jan 18:S1533-0028(24)00003-3. doi: 10.1016/j.clcc.2024.01.003. Online ahead of print. PMID: 38331650

Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704).

Gastric Cancer. 2024 Mar;27(2):366-374. doi: 10.1007/s10120-023-01453-7. Epub 2024 Jan 5. PMID: 38180622 Free PMC article. Clinical Trial.

Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106).

Int J Clin Oncol. 2023 Sep;28(9):1176-1182. doi: 10.1007/s10147-023-02376-0. Epub 2023 Jul 7. PMID: 37418143 Clinical Trial.

Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.

Gastric Cancer. 2023 Nov;26(6):1020-1029. doi: 10.1007/s10120-023-01423-z. Epub 2023 Aug 23. PMID: 37610558 Free PMC article. Clinical Trial.

Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction Cancer.

J Gastrointest Cancer. 2023 Sep;54(3):951-961. doi: 10.1007/s12029-023-00920-9. Epub 2023 Apr 10. PMID: 37037952 Free PMC article. Clinical Trial.

Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities.

Front Cell Infect Microbiol. 2022 Sep 14;12:925444. doi: 10.3389/fcimb.2022.925444. eCollection 2022. PMID: 36189350 Free PMC article.

Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study.

BMC Cancer. 2022 Jul 23;22(1):811. doi: 10.1186/s12885-022-09890-w. PMID: 35870893 Free PMC article.

Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S - 1 therapy.

BMC Cancer. 2022 Jul 15;22(1):773. doi: 10.1186/s12885-022-09844-2. PMID: 35840917 Free PMC article.

Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Multikinase Inhibitors for Patients with Advanced Gastric Cancer with or without Liver Metastases in Clinical Trials.

Clin Cancer Res. 2022 Aug 15;28(16):3480-3488. doi: 10.1158/1078-0432.CCR-22-0630. PMID: 35679062 Free PMC article.